TABLE 1.
URPL Group (n: 138) | Control Group (n: 139) | P | |
---|---|---|---|
Age | 30.7 ± 4.93 | 29.7 ± 4.1 | .106* |
Gravida | 4.0 (3‐8) | 2 (1‐6) | <.001** |
Parity | 0 (0‐4) | 2 (1‐6) | <.001** |
Height (cm) | 164 (145‐180) | 163 (147‐180) | .319** |
Weight (kg) | 66 (44‐109) | 67 (47‐120) | .087** |
Waist circumference (cm) | 88 (63‐124) | 83 (63‐118) | .002** |
Hip circumference (cm) | 108.5 (83‐130) | 103 (85‐129) | .039** |
BMI | 25.8 ± 5.1 | 25.0 ± 4.5 | .276* |
BRI | 4.4 ± 1.7 | 3.9 ± 1.5 | .016* |
ABSI | 0.08 ± 0.005 | 0.078 ± 0.004 | <.001* |
WtHR | 0.84 ± 0.06 | 0.82 ± 0.05 | .003* |
AMH (ng/mL) | 3.3 (0‐7.3) | 4.6 (0.3‐8.2) | <.001** |
AMH≤1 | 25 (18.1%) | 18 (12.9%) | .235*** |
AMH>1 | 113 (81.9%) | 121 (87.7%) | |
FSH (U/L) | 7.2 (3.8‐18.4) | 7.1 (1.9‐24) | .132** |
FSH<11 | 19 (13.8%) | 15 (10.8%) | .45*** |
FSH≥11 | 119 (86.2%) | 124 (89.2%) | |
E2 (nmol/L) | 46 (32‐82) | 47 (29‐78) | .135** |
E2<60 | 12 (8.7%) | 13 (9.4%) | .849*** |
E2≥60 | 126 (91.3%) | 126 (90.6%) |
Abbreviations: BRI, Body roundness index; ABSI, A body shape index; WtHR, Waist‐to‐hip ratio; URPL, Unexpected recurrent pregnancy loss.
Independent samples t test was performed
Mann‐Whitney U test was performed
Chi‐square test was performed.